Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.18% is 37% below its 5-year average of 3.47%, around the middle of its 5-year range (-16.82%–25.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 210.09% above its 12-month average of -1.98%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.18%.
RETURN ON EQUITY (ROE)
2.18%
RETURN ON EQUITY (ROE) AVG TTM
-1.98%
RETURN ON EQUITY (ROE) AVG 3Y
-2.12%
RETURN ON EQUITY (ROE) AVG 5Y
3.47%
RETURN ON EQUITY (ROE) AVG 10Y
-1.05%
RETURN ON EQUITY (ROE) AVG 15Y
-2.85%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+210.09%
CURRENT VS 3Y AVG
+202.79%
CURRENT VS 5Y AVG
-37.18%
CURRENT VS 10Y AVG
+307.36%
CURRENT VS 15Y AVG
+176.49%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 615 covered companies
CURRENT VS SECTOR MEDIAN
+105.42%
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$988.29M
Return on Equity (ROE)
2.18%
TTM Avg
-1.98%
3Y Avg
-2.12%
5Y Avg
3.47%
Market Cap
$987.23M
Return on Equity (ROE)
-15.09%
TTM Avg
46.85%
3Y Avg
62.20%
5Y Avg
62.20%
Market Cap
$990.91M
Return on Equity (ROE)
-32.27%
TTM Avg
-24.43%
3Y Avg
-32.70%
5Y Avg
-40.03%
Market Cap
$993.70M
Return on Equity (ROE)
36.64%
TTM Avg
876.73%
3Y Avg
395.64%
5Y Avg
252.56%
Market Cap
$998.31M
Return on Equity (ROE)
-25.78%
TTM Avg
29.18%
3Y Avg
31.59%
5Y Avg
31.59%
Market Cap
$1.01B
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$957.88M
Return on Equity (ROE)
-612.78%
TTM Avg
-101.05%
3Y Avg
-68.21%
5Y Avg
-52.21%
Market Cap
$1.02B
Return on Equity (ROE)
-4.51%
TTM Avg
-33.13%
3Y Avg
-42.62%
5Y Avg
-42.62%
Market Cap
$948.82M
Return on Equity (ROE)
-61.58%
TTM Avg
-50.64%
3Y Avg
-52.69%
5Y Avg
41.64%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $988.29M | 2.18% | -1.98% | -2.12% | 3.47% |
| Aktis Oncology, Inc. (AKTS)vs › | $987.23M | -15.09% | 46.85% | 62.20% | 62.20% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.91M | -32.27% | -24.43% | -32.70% | -40.03% |
| MeiraGTx Holdings plc (MGTX)vs › | $993.70M | 36.64% | 876.73% | 395.64% | 252.56% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $998.31M | -25.78% | 29.18% | 31.59% | 31.59% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $957.88M | -612.78% | -101.05% | -68.21% | -52.21% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -4.51% | -33.13% | -42.62% | -42.62% |
| MoonLake Immunotherapeutics (MLTX)vs › | $948.82M | -61.58% | -50.64% | -52.69% | 41.64% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $944.30M | N/A | 30.44% | 30.44% | 30.44% |
ROE
2.2%
ROA
1.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.18% |
| 2026-03-31 | 0.79% |
| 2025-12-31 | 1.01% |
| 2025-09-30 | 2.95% |
| 2025-06-30 | -16.82% |
| 2025-03-31 | -12.99% |
| 2024-12-31 | -12.79% |
| 2024-09-30 | -12.10% |
| 2024-06-30 | 7.23% |
| 2024-03-31 | 7.90% |
| 2023-12-31 | 4.82% |
| 2023-09-30 | 0.84% |
| 2023-06-30 | -0.57% |
| 2023-03-31 | -1.36% |
| 2022-12-31 | 2.05% |
| 2022-09-30 | 2.71% |
| 2022-06-30 | 5.19% |
| 2022-03-31 | 5.42% |
| 2021-12-31 | 5.75% |
| 2021-09-30 | 8.58% |
| 2021-06-30 | 25.33% |
| 2021-03-31 | 22.70% |
| 2020-12-31 | 23.48% |
| 2020-09-30 | 21.57% |
| 2020-06-30 | -2.60% |
| 2020-03-31 | -0.02% |
| 2019-12-31 | -3.10% |
| 2019-09-30 | 0.62% |
| 2019-06-30 | 2.23% |
| 2019-03-31 | 2.27% |
| 2018-12-31 | -0.15% |
| 2018-09-30 | -1.38% |
| 2018-06-30 | -3.83% |
| 2018-03-31 | -12.00% |
| 2017-12-31 | -15.25% |
| 2017-09-30 | -19.33% |
| 2017-06-30 | -25.19% |
| 2017-03-31 | -19.94% |
| 2016-12-31 | -17.33% |
| 2016-09-30 | -17.03% |
| 2016-06-30 | -4.92% |
| 2016-03-31 | -1.44% |
| 2015-12-31 | 0.85% |
| 2015-09-30 | 4.86% |
| 2015-06-30 | 2.08% |
| 2015-03-31 | -0.53% |
| 2014-12-31 | -8.01% |
| 2014-09-30 | -20.30% |
| 2014-06-30 | -29.23% |
| 2014-03-31 | -146.31% |
| 2013-12-31 | -154.93% |
| 2013-09-30 | -139.05% |
| 2013-06-30 | -117.11% |
| 2013-03-31 | -91.02% |
| 2012-12-31 | -79.39% |
| 2012-09-30 | -63.67% |
| 2012-06-30 | -47.60% |
| 2012-03-31 | -122.03% |
| 2011-12-31 | -89.77% |
| 2011-09-30 | -252.90% |
| 2011-06-30 | -145.99% |
| 2011-03-31 | -101.24% |
